| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
—Aerovate Board of Directors approves 1-for-35 reverse stock split—WALTHAM, Mass., April 21, 2025 /PRNewswire/ -- Aerovate Ther...
Aggregate cash dividend of $69.6 million, or an estimated $2.40 per shareWALTHAM, Mass., April 9, 2025 /PRNewswire/ -- Aerovate...
Merger to create a company focused on advancing Jade Biosciences' portfolio of novel therapies that aim to redefine the sta...